Atlas Trials

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

Clinical trial NCT04723121 · COMPLETED

Trial details

NCT number
NCT04723121
Sponsor
Mansoura University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2013-03-01
Primary completion
2019-05-01
Enrollment
204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.